Early diagnosis is critical for preventing severe outcomes. Most countries have implemented newborn screening programs that test for elevated levels of thyroid-stimulating hormone (TSH) and low levels of thyroxine (T4). These tests are typically done within the first few days of life through a heel-prick blood sample.
